View original content: https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-inc-announces-exercise-of-warrants-for-2-67-million-gross-proceeds-302484551.html ...

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) remained free ...

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) ...

Former Bellator MMA and ONE Championship welterweight kingpin, Ben Askren is reportedly in critical condition tonight as he battles a severe staph infection, with his wife, Amy confirming the ...

Antibiotic resistance is the ability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. Antibiotic resistance evolves naturally via natural ...

Vancomycin-resistant Enterococcus faecium (VRE) is a frequent cause of bacteremia in immunocompromised patients and there exists only two antibiotics that are effective for treating VRE infection. In ...

Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for ... (HR, 1.41; 95% CI, 1.32-1.51). No association was ...

More than half of all VRE infections occurred within 90 days of initial colonization. Factors associated with reduced risk for VRE infection included older age (>65 years; HR, 0.52; 95% CI, 0.44-0.63) ...

A systematic review and meta-analysis found that room disinfection with ultraviolet-C (UV-C) devices had little impact on the incidence of healthcare-associated multidrug-resistant organism (MDRO) ...